Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Jack bean alpha-mannosidase is a zinc-dependent glycosyl hydrolase (EC 3.2.1.24) purified from the seeds of the Jack bean plant, Canavalia ensiformis (UniProt: P80033). It belongs to the Glycosyl Hydrolase Family 38 (GH38) and is characterized by its ability to hydrolyze terminal, non-reducing alpha-D-mannose residues from various glycoconjugates (CAZy Database). In the field of glycobiology, this enzyme is a standard tool for the structural analysis and sequencing of N-linked oligosaccharides due to its broad substrate specificity. Although it is a plant-derived enzyme, it serves as a primary biochemical model for human alpha-mannosidases, which are involved in glycoprotein maturation and lysosomal degradation. It is frequently used in drug discovery as a surrogate target to screen for inhibitors like swainsonine, which are investigated for their anti-tumor and immunomodulatory properties (PMID: 1566718). These inhibitors typically act by mimicking the transition state of the mannosyl residue, thereby competitively blocking the enzyme's active site (PMID: 8413645). Consequently, Jack bean alpha-mannosidase plays a vital role in understanding the pharmacology of glycomimetics intended for treating cancer, viral infections, and metabolic disorders.
Competitive inhibition of the catalytic site by transition-state analogs, preventing the cleavage of terminal alpha-mannosyl residues from glycoproteins (PMID: 8413645).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-mannosidase (Jack bean) (JBM).